<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220206053950N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-09-07</date_registration>
      <primary_sponsor>Zanjan University of Medical Sciences</primary_sponsor>
      <public_title>Effectiveness of muscle strengthening exercises on knee osteoarthritis</public_title>
      <acronym></acronym>
      <scientific_title>Effectiveness of muscle strengthening exercises on pain, physical function and morning stiffness of patients with osteoarthritis of knee : a randomized four-arm controlled trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2016-02-25</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>96</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/65073</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: The participants were asked to regularly perform exercises 5 days a week, for 8 weeks (3 sets/day, 10-15 repetitions). To ensure regular exercising according to the instructions, the participants were provided with written instructions of the exercise programs and a specific form to record their daily exercises during 8 weeks, in addition, they were telephoned once a week by the physiotherapist, encouraging patients to properly adhere to the interventions, Randomization description: Random sequence was made by Microsoft Excel using the RAND() function of this software. A 1:1:1:1 allocation was made by an independent investigator using Blocked randomization with randomly varying blocks of 4 and 8 and stratified randomization considering Kellgren-Lawrence grade 1-2 or 3. The allocation sequence was concealed from the investigator enrolling and assessing participants in sequentially numbered, opaque, sealed envelopes, Blinding description: The present study is single-blind. The principal investigator, outcome assessor, and data collector are blinded by not informing them of the group allocation. Data analyst is kept masked by providing a blinded version of data.
The care provider and the participants are not blinded. Considering the nature of the intervention, which is an exercise therapy, and the fact that the control group does not receive any intervention, naturally, it is not possible to blind the participants and care providers during the trial.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Osteoarthritis of knee.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: received home-based quadriceps strengthening exercises, regularly perform 3 sets of exercises per day, 10-15 repetitions, 5 days a week for 8 weeks. Intervention 2: Intervention group: received home-based hamstring strengthening exercises, regularly perform 3 sets of exercises per day, 10-15 repetitions, 5 days a week for 8 weeks. Intervention 3: Intervention group: received home-based strengthening both quadriceps and hamstring muscles groups, regularly perform 3 sets of exercises per day, 10-15 repetitions, 5 days a week for 8 weeks. Intervention 4: Control group: did not receive the intervention during this period.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no more information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mina Rostami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 4511, Helal 1Alley, Avesta Ave., Phase 3, Golshahr Town</address>
        <city>Zanjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4514151659</zip>
        <telephone>+98 991 207 7996</telephone>
        <email>mina.rostami1373@gmail.com</email>
        <affiliation>Zanjan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mina Rostami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 4511, Helal 1 Ave, Golshahr, Zanjan.</address>
        <city>Zanjan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4514151659</zip>
        <telephone>+98 991 207 7996</telephone>
        <email>mina.rostami1373@gmail.com</email>
        <affiliation>Zanjan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with knee osteoarthritis (grades I-III in the Kellgren-Lawrence score)
Patients aged 40-70 years
Patients who had pain, morning stiffness of shorter than 30 minutes, or knee crepitus.</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Concomitant involvement with musculoskeletal diseases other than knee osteoarthritis in one or both knees within the last 6 months
A history of knee joint surgery
Intra-articular injection of corticosteroids or hyaluronic acid in the knee joints within the past 30 days
Non-steroidal anti-inflammatory drugs (NSAIDs) or glucosamine intake within the last 30 days
Participation in the muscle-strengthening programs for the knee joint within the last 6 months</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M17</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Osteoarthritis of knee</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: received home-based quadriceps strengthening exercises, regularly perform 3 sets of exercises per day, 10-15 repetitions, 5 days a week for 8 weeks.</i_keyword>
      <i_keyword>Intervention group: received home-based hamstring strengthening exercises, regularly perform 3 sets of exercises per day, 10-15 repetitions, 5 days a week for 8 weeks.</i_keyword>
      <i_keyword>Intervention group: received home-based strengthening both quadriceps and hamstring muscles groups, regularly perform 3 sets of exercises per day, 10-15 repetitions, 5 days a week for 8 weeks.</i_keyword>
      <i_keyword>Control group: did not receive the intervention during this period.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Score of knee pain on Visual Analogue Scale (VAS) score. Timepoint: At the beginning of the study (before the intervention) and 8 weeks after the initiation of the exercise therapy. Method of measurement: Visual Analogue Scale (VAS).</prim_outcome>
      <prim_outcome>Score of knee physical function on the Western Ontario and McMaster (WOMAC) Index. Timepoint: At the beginning of the study (before the intervention) and 8 weeks after the initiation of the exercise therapy. Method of measurement: Western Ontario and McMaster (WOMAC) Index.</prim_outcome>
      <prim_outcome>Score of knee morning stiffness on the Western Ontario and McMaster (WOMAC) Index. Timepoint: At the beginning of the study (before the intervention) and 8 weeks after the initiation of the exercise therapy. Method of measurement: Western Ontario and McMaster (WOMAC) Index.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Zanjan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-02-18</approval_date>
        <contact_name>Ethics committee of Zanjan University of Medical Sciences</contact_name>
        <contact_address>Room No. 22, First Floor, Ethics Committee in Biomedical, Vice-Chancellor for Research and Technology, Azadi Blvd., Zanjan Zanjan Zanjan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
